X
14May

Biosimilar Buyouts: AbbVie Buyout of Allergan Receives Approval of Irish High Court; Gedeon Richter Buys Tocilizumab Biosimilar

Goodwin | | Return|
On May 8, 2020, AbbVie announced that it completed its acquisition of Allergan plc, having received approval by the Irish High Court. AbbVie and Allergan had previously announced, on May 5, 2020, that the U.S. Federal Trade Commission accepted the...
By: Goodwin
Source Url: https://www.jdsupra.com/legalnews/biosimilar-buyouts-abbvie-buyout-of-67063/

Related

Construction Projects and Disputes: A Look Beyond the Lockdown, Part III

[co-author: Juan Huertas] Even as the world gradually eases out of lockdown, deals are rekindled an...

Read More >

Second Circuit Sends Home Care Worker’s Putative Class Claims to Union Arbitration on an Individual Basis

On July 2, 2019, the U.S. Court of Appeals for the Second Circuit handed a significant victory to Ne...

Read More >

Governor Cuomo Announces Plan to Eliminate Tip Credit for Employees Outside the Hospitality Industry

The New York State Department of Labor, after holding multiple hearings across the state regarding t...

Read More >

EBITDA, Adjusted EBITDA, and EBITDAC in the Age of COVID-19

The definition earnings before interest, taxes, depreciation and amortization (“EBITDA”) and adjus...

Read More >

New California Legislation Makes it More Difficult to Classify Workers as Independent Contractors

California Assembly Bill 5 has been branded as the killer of the gig economy. It adds to the Califor...

Read More >

Seyfarth Policy Matters Newsletter - January 2020 #2

With the eyes of Capitol Hill squarely focused on the Senate impeachment proceedings, we turn this w...

Read More >